Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib
| Authors | |
|---|---|
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | Clinical lymphoma & myeloma |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | Varicella-zoster virus; acyclovir; multiple myeloma |
| Description | Varicella-zoster virus (VZV) reactivation is a common complication in patients with multiple myeloma (MM) treated with bortezomib, with an incidence rate of 10%-60%. The aim of our study was to analyze the effect of acyclovir prophylaxis in this patient population. |
| Related projects: |